共 17 条
- [2] Evaluation for the withdrawal syndrome from γ-hydroxybutyric acid (GHB), γ-butyrolactone (GBL), and 1,4-butanediol (1,4-BD) in different rat lines CELLULAR AND MOLECULAR MECHANISMS OF DRUGS OF ABUSE AND NEUROTOXICITY: COCAINE, GHB, AND SUBSTITUTED AMPHETAMINES, 2006, 1074 : 545 - 558
- [4] Gammahydroxybutyrate (GHB) and precursors, gammabutyrolactone (GBL) and 1,4-butanediol (1,4-BD) in France THERAPIE, 2024, 79 (06):
- [5] Self-administration of gamma-hydroxybutyric acid (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons Psychopharmacology, 2013, 225 : 637 - 646
- [8] Behavioral effects and pharmacokinetics of gamma-hydroxybutyrate (GHB) precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4-BD) in baboons Psychopharmacology, 2009, 204 : 465 - 476
- [9] Withdrawal syndrome from γ-hydroxybutyric acid (GHB) and 1,4-butanediol (1,4-BD) in Sardinian alcohol-preferring rats BRAIN RESEARCH PROTOCOLS, 2005, 15 (02): : 75 - 78
- [10] Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2015, 53 : 52 - 78